+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
From
From
From
From
From
AbbVie Hit Harder By EU Humira Biosimilars Than Projected - Product Thumbnail Image

AbbVie Hit Harder By EU Humira Biosimilars Than Projected

  • Newsletter
  • February 2026
  • 3 Pages
  • Europe
From
Dermatologicals in Brazil - Product Thumbnail Image

Dermatologicals in Brazil

  • Report
  • December 2025
  • 26 Pages
  • Brazil
From
Dermatologicals in Algeria - Product Thumbnail Image

Dermatologicals in Algeria

  • Report
  • December 2025
  • 20 Pages
  • Algeria
From
Dermatologicals in the Philippines - Product Thumbnail Image

Dermatologicals in the Philippines

  • Report
  • November 2025
  • 24 Pages
  • Philippines
From
From
From
From
From
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more